Loading…
A Revolutionary Research Based Evidently Effective Herbo-Mineral Ayurvedic Formulation. Pack of 2 (10 x 2 Doses) Fast acting, Non sedative, Non Steroidal, Anti Histaminic, Natural killer cell properties Start responding within first 2 to15 minutes of consuming the 1st dose in the patients suffering from Acute Allergic Rhinitis Combination of 18 herbs and Mandoor bhasma, manufactured by Bharat Bhaishajya Shala Each batch of this Ayurvedic formulation follows strict quality assurance protocol till the finishing stage
Hepato-protective, Anti-fibrotic, Immuno-modulator, Anti-inflammatory, De-toxifier, Anti-histaminic (anti-allergic), Natural Killer cell properties (immune-modulator)
Non-steroidal, Devoid of chemicals, Natural product, No Grade II toxicity.
Manufactured under Mfg. Lic. No. UK.AY-556/2024 by Bharat Bhaishajya Shala Pvt. Ltd., Gadarpur, Udham Singh Nagar, Uttarakhand. Take on the advice of a qualified practitioner, particularly alongside prescribed medicines or during pregnancy.
The problem
Allergic rhinitis rarely announces itself as an illness. It shows up as a morning that starts with six sneezes, a nose that blocks the moment the season turns, eyes that water in a dusty room. Most people stop calling it a condition and start calling it normal.
The usual answer is an antihistamine. It works for a few hours, and you take another tomorrow. It manages the symptom while leaving the response that produced it untouched, which is why the tablet becomes a daily habit rather than a course of treatment.
Symptoms measured in the trial
Why it persists
An allergic response begins with IgE, an antibody the immune system makes against something harmless. Dust, pollen, a change in the weather. Once IgE is bound to mast cells in the nasal lining, the next exposure ruptures them, releasing histamine and the familiar cascade of symptoms.
Antihistamines block the receptor histamine acts on. They don't lower IgE, and they don't change how readily the mast cells release it. IMMBO was formulated to work further upstream, and that is what the trial set out to measure.
From the shala
Made at our own facility in Uttarakhand, under Mfg. Lic. No. UK.AY-556/2024, by the family that has run Bharat Bhaishajya Shala since 1945.
The immune system produces IgE against an ordinary substance and attaches it to mast cells in the nasal lining.
On the next exposure those mast cells rupture, releasing histamine and inflammatory mediators.
Blood vessels dilate, mucus production rises, nerve endings fire. The result is sneezing, congestion, itching and watering.
The formulation
18 Ayurvedic herbs + Mandoor Bhasma
IMMBO derives from Punarnava Mandoor, a classical formulation, refined over three decades of clinical use. The mineral component is Mandoor Bhasma: iron oxide put through classical Shodhana and Marana purification before it enters the formula.
Classical source
Punarnava Mandoor
Each 1000 mg sachet contains · 19
As listed on immbo.in, per sachet.
The evidence
In 2023 an open-label randomised controlled trial of IMMBO in allergic rhinitis was published in Cureus and indexed on PubMed Central. It compared IMMBO against a conventional combination of levocetirizine and montelukast over 28 days.
Total Nasal Symptom Score reduction
Complete symptom resolution
IgE reduction
Design 250 patients screened, 224 enrolled and randomised 1:1. IMMBO group n=114 at 60 mg/kg/day in three divided doses; comparison group n=110 on levocetirizine 2.5 mg plus montelukast 4 mg once daily. Assessed at baseline, day 14 and day 28.
No serious adverse events were reported in either group. The authors describe the trial as establishing prima facie evidence, and note it requires further scientific development to confirm long-term benefit.
Published as
Vaidya B Prakash, Yashwant K Rao, Shikha Prakash, Sneha T Sati, Ankita Mohapatra, Neha Negi. Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial. Cureus. 2023;15(10):e46663.
DOI 10.7759/cureus.46663 · PMID 37942368
Read the full paperUsage
Dosage
Three sachets a day, or as directed by your physician
Open and swallow. No mixing, no decoction, no tablets.
IMMBO is supplied as single-dose sachets taken directly. The trial dosed at 60 mg/kg/day in three divided doses over 28 days.
Days 1–14
The trial's first assessment point. Symptom scores measured against baseline.
Day 28
Trial endpoint. This is where the published resolution and IgE figures were recorded.
Beyond
Long-term use should be under the guidance of a qualified physician.
Safety
IMMBO is non-sedative and contains no steroids. In the published trial no serious adverse events were reported in either arm.
Individual responses vary. This information is not a substitute for medical advice.
FAQ
An antihistamine blocks the receptor that histamine acts on, which relieves symptoms for a few hours. The published trial measured IMMBO against a levocetirizine and montelukast combination over 28 days and recorded a greater reduction in both nasal symptom score and serum IgE.
IMMBO is non-sedative. No serious adverse events were reported in either arm of the published trial.
The published trial assessed patients at day 14 and day 28. Individual responses vary, so ask your physician what to expect in your case.
Discuss it with your physician. In the published trial one arm received IMMBO together with conventional treatment.
Mandoor Bhasma is purified iron oxide, prepared through the classical Shodhana and Marana process before it enters the formula. It has been used in classical Ayurvedic practice for centuries and is manufactured here under licence.
Eighteen Ayurvedic herbs and Mandoor Bhasma, derived from the classical formulation Punarnava Mandoor. The full list is set out above.
Reviews
No reviews of IMMBO (Pack of 2) yet. If you’ve used it, yours would be the first.
